08 | What this review is for
CJC-1295 is a man-made peptide, a chain of protein building blocks.
Here's what this CJC-1295 review can tell you, what it can't, and why the limits matter.
What can this review tell you?
CJC-1295 Meds explains the published work on CJC-1295. The main human paper is Teichman's from 2006, which tested both the long-lasting and short-lasting forms. On every page we say whether a claim comes from people, mice, clinics or online posts, because those aren't equal kinds of proof.
No clinic or doctor stands behind this site. It gives no medical advice and writes no prescriptions. It makes, sells and ships nothing. Its job is narrower: telling you what the papers found and what they didn't.
Does 'meds' mean this site provides medicine?
No. The word 'meds' in cjc1295meds.com doesn't mean this site provides medicine. CJC-1295 isn't FDA approved as a drug. A few original studies sit beneath a great many sales claims online. We treat those claims as medical claims and ask what the papers truly showed. The name isn't an offer to sell or provide a product.
Which papers carry the most weight here?
Wherever a page gives a figure, the small number in square brackets after it points to the paper or public record it came from, listed on the references page. The papers we lean on most are Teichman's human work from 2006, Alba's mouse work from 2006, Coy's 1994 study on how long the request lasts, and Raun's 1998 ipamorelin study. We also use FDA's 2024 pharmacy review and the sports ban. Some papers only show that a seized product contained the peptide. That tells you what was in the vial, not whether it helps anyone.
A mouse result isn't advice for you, and neither is an online post. This site doesn't back the compound, suggest using it, or rank sellers.
Why won't this review make a treatment pitch?
Because the evidence can't carry one. The human work on CJC-1295 mostly found changes in hormone blood tests. It didn't show anyone felt better, lived longer, or stayed clear of illness. No clinic's sales line fills that gap. The site's dark look borrows from design studios such as Field.io, and a look tells you nothing about safety.